article
The route to enhanced gene therapies
In this article, Roger Palframan, Head of US Research at…
In this article, Roger Palframan, Head of US Research at UCB, delves into the potential of gene therapy and which modalities have the most promise, what the industry should prioritise to advance the field, as well as what is needed to develop the workforce.
